跳至主要内容
临床试验/ISRCTN79457541
ISRCTN79457541已完成未知

'Diabetescoach' – personal health coaching in patients with type 2 diabetes mellitus: a randomized controlled trial

niversity of Basel0 个研究点目标入组 90 人开始时间: 2021年2月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35649615/ (added 08/06/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 15/06/2021:
  • Type 2 diabetes patients will be included in the study if they:
  • 1. Have an HbA1c value above 7.5
  • 2. Have type 2 diabetes as defined by the American Diabetes Association
  • 3. Are able to understand German at a sufficient level to comprehend instructions and information
  • 4. Have access to ongoing treatment for type 2 diabetes by a primary care physician or diabetologist
  • 5. Have an Internet connection
  • 6. Have an activity level of less than 150 minutes of moderate or 75 minutes of intensive physical activity per week
  • Previous inclusion criteria:
  • Type 2 diabetes patients will be included in the study if they:
  • 1. Are between 18-65 years old
  • 2. Have an HbA1c value above 7.5
  • 3. Have type 2 diabetes as defined by the American Diabetes Association
  • 4. Are able to understand German at a sufficient level to comprehend instructions and information
  • 5. Have access to ongoing treatment for type 2 diabetes by a primary care physician or diabetologist
  • 6. Have an Internet connection
  • 7. Have an activity level of less than 150 minutes of moderate or 75 minutes of intensive physical activity per week

排除标准

  • Patients with type 2 diabetes must be excluded from the study if:
  • 1. They have chronic or acute contraindications to physical activity or cannot be physically active for other medical reasons
  • 2. They suffer from psychiatric or addiction disorders
  • 3. They are pregnant
  • 4. Insulin therapy is being used
  • 5. If the HbA1c value cannot be reliably determined due to medical conditions (in the case of hemoglobinopathy, hemolytic anemia, blood transfusion, HIV, liver or kidney failure requiring dialysis)

研究者

发起方
niversity of Basel

相似试验